Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A45820 | 22532403 | Magn Reson Med | Simultaneous quantification of fat content and fatty acid composition using MR imaging. | 2012 | Details |
| A45821 | 22531045 | Drug Metab Dispos | In vitro hepatotoxicity and cytochrome P450 induction and inhibition characteristics of carnosic acid, a dietary supplement with antiadipogenic properties. | 2012 | Details |
| A45822 | 22527892 | Endocrine | Anti-oxidant therapy in non-alcoholic fatty liver disease: the role of silymarin. | 2012 | Details |
| A45823 | 22522383 | J Hepatol | Focus. Metchnikoff, macrophages and the metabolic syndrome. | 2012 | Details |
| A45824 | 22511912 | Korean J Hepatol | Body iron, serum ferritin, and nonalcoholic fatty liver disease. | 2012 | Details |
| A45825 | 22511898 | Korean J Hepatol | Revision and update on clinical practice guideline for liver cirrhosis. | 2012 | Details |
| A45826 | 22505369 | Hepatology | Cardiovascular phenotype of nonalcoholic fatty liver disease: hanging the paradigm about the role of distant toxic fat accumulation on vascular disease. | 2012 | Details |
| A45827 | 22505349 | Hepatology | The mechanism behind the novel fibrosis recently described in NASH in HEPATOLOGY 2011 and elsewhere. | 2012 | Details |
| A45828 | 22505342 | Hepatology | Hedgehog/hyaluronic acid interaction network in nonalcoholic fatty liver disease, fibrosis, and hepatocellular carcinoma. | 2012 | Details |
| A45829 | 22490528 | Gut | NKT cells and the hedgehog pathway: an unhealthy marriage in non-alcoholic fatty liver disease? | 2012 | Details |
| A45830 | 22488764 | Hepatology | The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. | 2012 | Details |
| A45831 | 22487461 | Dig Liver Dis | If steatosis is the atherosclerosis of the liver, are statins the "aspirin" for steatosis? | 2012 | Details |
| A45832 | 22484034 | Biochim Biophys Acta | PFOS-induced hepatic steatosis, the mechanistic actions on β-oxidation and lipid transport. | 2012 | Details |
| A45833 | 22481465 | Ann Hepatol | Causes of death after liver transplantation. | 2012 | Details |
| A45834 | 22471112 | Rev Med Suisse | [Lipid-lowering treatment and liver dysfunction]. | 2012 | Details |
| A45835 | 22467903 | J Int Assoc Physicians AIDS Care (Chic) | Low prevalence of chronic hypertransaminasemia in a cohort of HIV-infected patients with no coinfections. | 2014 | Details |
| A45836 | 23798298 | Compr Physiol | Lack of exercise is a major cause of chronic diseases. | 2012 | Details |
| A45837 | 22461076 | Hepatology | The TONIC trial: a step forward in treating pediatric nonalcoholic fatty liver disease. | 2012 | Details |
| A45838 | 22447258 | Semin Respir Crit Care Med | Sleep disorders in chronic liver disease. | 2012 | Details |
| A45839 | 22441585 | MAGMA | Hepatic lipid composition differs between ob/ob and ob/+ control mice as determined by using in vivo localized proton magnetic resonance spectroscopy. | 2012 | Details |
| A45840 | 22436056 | J Gastroenterol Hepatol | Is impaired Kupffer cell function really important to the pathogenesis of nonalcoholic steatohepatitis? | 2012 | Details |
| A45841 | 22434747 | Pediatr Obes | Sensitive non-invasive circulating markers in paediatric non-alcoholic fatty liver disease. | 2012 | Details |
| A45842 | 22433603 | J Hepatol | The optimal dose of omega-3 supplementation for non-alcoholic fatty liver disease. | 2012 | Details |
| A45843 | 22429485 | Liver Int | Oxidative stress rather than triglyceride accumulation is a determinant of mitochondrial dysfunction in in vitro models of hepatic cellular steatosis. | 2012 | Details |
| A45844 | 22428436 | Pediatr Med Chir | [Pediatric steatohepatitis: is it only obesity?]. | 2012 | Details |
| A45845 | 22425588 | Gastroenterology | Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects. | 2012 | Details |
| A45846 | 22423369 | Zhonghua Gan Zang Bing Za Zhi | [Clinical observation of Qianggan capsule in the treatment of non-alcoholic of non-alcoholic fatty liver fibrosis]. | 2011 | Details |
| A45847 | 22422583 | Hepatology | Beyond reasonable doubt: who is the culprit in lipotoxicity in NAFLD/NASH? | 2012 | Details |
| A45848 | 22405038 | Liver Int | Noninvasive assessment of the effect of treatment in nonalcoholic fatty liver disease: neutrophil to lymphocyte ratio. | 2012 | Details |
| A45849 | 22397876 | Nutr Metab Cardiovasc Dis | No association between the degree of liver steatosis and early signs of vasculopathy in T2DM. | 2012 | Details |
| A45850 | 22388885 | J Gastroenterol | Thrombocytopenia is more severe in patients with chronic hepatitis C than in patients with nonalcoholic fatty liver disease. | 2012 | Details |
| A45851 | 22387255 | Clin Gastroenterol Hepatol | Nonalcoholic fatty liver disease and cardiovascular disease risk. | 2012 | Details |
| A45852 | 22386938 | Metabolism | Sulfated oxysterols as candidates for the treatment of nonalcoholic fatty liver disease. | 2012 | Details |
| A45853 | 22383493 | Am J Physiol Gastrointest Liver Physiol | When GLP-1 hits the liver: a novel approach for insulin resistance and NASH. | 2012 | Details |
| A45854 | 22371574 | Proc Natl Acad Sci U S A | Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice. | 2012 | Details |
| A45855 | 22371327 | Hepatology | Diagnostic accuracy of adipose insulin resistance index and visceral adiposity index for progressive liver histology and cardiovascular risk in nonalcoholic fatty liver disease. | 2012 | Details |
| A45856 | 22369128 | J Gastroenterol Hepatol | APOC3 and PNPLA3 in non-alcoholic fatty liver disease: need to clear the air. | 2012 | Details |
| A45857 | 22362822 | J Clin Endocrinol Metab | Prevalence, incidence, and prognosis of hepatobiliary disease in community-based patients with type 2 diabetes: the Fremantle Diabetes Study. | 2012 | Details |
| A45858 | 22359907 | Acta Med Croatica | [Chronic liver diseases in patients with chronic kidney disease]. | 2011 | Details |
| A45859 | 25755414 | J Clin Exp Hepatol | It is Patatin-like Phospholipase Domain-containing 3 Gene (PNPLA3)-All the Way. | 2012 | Details |
| A45860 | 22357996 | AJR Am J Roentgenol | MRI steatosis grading: development and initial validation of a color mapping system. | 2012 | Details |
| A45861 | 22342919 | Clin Biochem | Unconjugated hyperbilirubinemia and liver histology in patients with non-alcoholic fatty liver disease. | 2012 | Details |
| A45862 | 22340732 | Liver Int | Neutrophil to lymphocyte ratio: a hopeful marker predicting the disease severity in patients with nonalcoholic fatty liver disease. | 2012 | Details |
| A45863 | 22330258 | Toxicology | Susceptibility to gold nanoparticle-induced hepatotoxicity is enhanced in a mouse model of nonalcoholic steatohepatitis. | 2012 | Details |
| A45864 | 22311368 | Dig Dis Sci | Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease. | 2012 | Details |
| A45865 | 22307871 | Hepatology | Assessment by Fibroscan of fibrosis in nonalcoholic fatty liver disease: XL versus M probe? | 2012 | Details |
| A45866 | 22301380 | J Cardiothorac Vasc Anesth | Evaluation of hepatic structures by transesophageal echocardiography. | 2012 | Details |
| A45867 | 22295144 | Int J Clin Exp Pathol | Protective effect of xanthohumol on toxin-induced liver inflammation and fibrosis. | 2012 | Details |
| A45868 | 27024388 | Harv Womens Health Watch | What to do about nonalcoholic fatty liver disease. It once seemed that only people who drank excessively were at risk for fatty liver disease. Not anymore. | 2012 | Details |
| A45869 | 22285146 | Dig Liver Dis | Screening for liver fibrosis by using FibroScan(®) and FibroTest in patients with diabetes. | 2012 | Details |
| A45870 | 22283096 | Diabetes Self Manag | Diabetes definitions. | 2012 | Details |
| A45871 | 22271617 | Liver Transpl | Use of the subcutaneous route and polytetrafluoroethylene grafts for arterial revascularization in liver transplantation. | 2012 | Details |
| A45872 | 22260279 | J Gastroenterol Hepatol | Integrated bioinformatics analysis of microRNA expression profiles for an in-depth understanding of pathogenic mechanisms in non-alcoholic fatty liver disease. | 2012 | Details |
| A45873 | 22248426 | Aliment Pharmacol Ther | Visceral adiposity index and exercise in non-alcoholic fatty liver disease. | 2012 | Details |
| A45874 | 22237882 | JPEN J Parenter Enteral Nutr | Nonalcoholic fatty liver disease in pediatric patients--a problem that is "enormous" and "growing"! | 2012 | Details |
| A45875 | 22243683 | Lipids Health Dis | Cyanidin-3-O-β-glucoside regulates fatty acid metabolism via an AMP-activated protein kinase-dependent signaling pathway in human HepG2 cells. | 2012 | Details |
| A45876 | 22242725 | Expert Opin Pharmacother | Managing the combination of non-alcoholic fatty liver disease and metabolic syndrome. | 2012 | Details |
| A45877 | 22234978 | Gut | Guidelines for liver transplantation for patients with non-alcoholic steatohepatitis. | 2012 | Details |
| A45878 | 22230269 | Am Fam Physician | Cirrhosis: diagnosis, management, and prevention. | 2011 | Details |
| A45879 | 22227071 | Nutr Metab Cardiovasc Dis | Lower plasma NAMPT/visfatin levels are associated with impaired hepatic mitochondrial function in non-diabetic obese women: a potential link between obesity and non-alcoholic fatty liver disease. | 2012 | Details |
| A45880 | 22225954 | Metabolism | Oxysterol sulfation by cytosolic sulfotransferase suppresses liver X receptor/sterol regulatory element binding protein-1c signaling pathway and reduces serum and hepatic lipids in mouse models of nonalcoholic fatty liver disease. | 2012 | Details |
| A45881 | 22219592 | World J Gastroenterol | Impact of liver diseases on the development of type 2 diabetes mellitus. | 2011 | Details |
| A45882 | 22218226 | Atherosclerosis | Hepatitis C virus and atherosclerosis in a close and dangerous liaison. | 2011 | Details |
| A45883 | 22212974 | Mayo Clin Proc | 52-year-old man with liver enzyme abnormalities and elevated ferritin level. | 2012 | Details |
| A45884 | 22212963 | Mayo Clin Proc | Hepatocellular carcinoma in olmsted county, Minnesota, 1976-2008. | 2012 | Details |
| A45885 | 22209682 | J Nutr Biochem | Oleic acid activates peroxisome proliferator-activated receptor δ to compensate insulin resistance in steatotic cells. | 2011 | Details |
| A45886 | 24713805 | Ann Gastroenterol | Cardiovascular disease in patients with non-alcoholic fatty liver disease. | 2012 | Details |
| A45887 | 22194736 | Exp Diabetes Res | Diabetes and nonalcoholic fatty liver disease. | 2011 | Details |
| A45888 | 22189977 | Semin Liver Dis | The impact of human gene polymorphisms on HCV infection and disease outcome. | 2011 | Details |
| A45889 | 22188024 | J Gastroenterol Hepatol | Histological features of non-alcoholic fatty liver disease: what is important? | 2012 | Details |
| A45890 | 22187655 | J Lipids | Nuclear receptors in nonalcoholic Fatty liver disease. | 2011 | Details |
| A45891 | 22181567 | Pediatr Int | Non-alcoholic steatohepatitis caused by malnutrition after pediatric liver transplantation. | 2011 | Details |
| A45892 | 22175150 | Nihon Naika Gakkai Zasshi | [Case report; Diabetes insipidus accompanied with acute kidney injury, which was revealed by acute fatty liver of pregnancy]. | 2011 | Details |
| A45893 | 22167651 | Methods Mol Biol | Mesenchymal stem cell therapy on murine model of nonalcoholic steatohepatitis. | 2012 | Details |
| A45894 | 22166577 | Ann Hepatol | Hormone replacement therapy in menopausal women: risk factor or protection to nonalcoholic fatty liver disease? | 2012 | Details |
| A45895 | 22166576 | Ann Hepatol | Is it appropriate to study blood ghrelin and obestatin in non-alcoholic fatty liver disease (NAFLD) without using protease inhibitors? | 2012 | Details |
| A45896 | 22157220 | J Clin Gastroenterol | Gastrointestinal and hepatic manifestations of Sjogren syndrome. | 2012 | Details |
| A45897 | 22154323 | Metabolism | Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet-fed KK-Ay mice. | 2011 | Details |
| A45898 | 22153811 | Transl Res | Mitochondrial polymorphism 12361A>G is associated with nonalcoholic fatty liver disease. | 2011 | Details |
| A45899 | 22152394 | Zhonghua Gan Zang Bing Za Zhi | [Difference between non-alcoholic fatty liver disease and alcoholic liver disease]. | 2011 | Details |
| A45900 | 22152377 | Zhonghua Gan Zang Bing Za Zhi | [The pathophysiological role of gut in non-alcoholic fatty liver disease]. | 2011 | Details |
| A45901 | 22152376 | Zhonghua Gan Zang Bing Za Zhi | [Cross-talk between endoplasmic reticulum and mitochondria in non-alcoholic fatty liver disease]. | 2011 | Details |
| A45902 | 22152375 | Zhonghua Gan Zang Bing Za Zhi | [Pancreatic derived factor (PANDER) and non-alcoholic fatty liver disease (NAFLD)]. | 2011 | Details |
| A45903 | 22152374 | Zhonghua Gan Zang Bing Za Zhi | [The role of inflammation related ectopic lipid deposition in non-alcoholic fatty liver disease]. | 2011 | Details |
| A45904 | 22152339 | Nutr Metab (Lond) | Transcriptome analysis of anti-fatty liver action by Campari tomato using a zebrafish diet-induced obesity model. | 2011 | Details |
| A45905 | 22152250 | Zhonghua Gan Zang Bing Za Zhi | [Efficacy comparison between bicyclol and polyene phosphatidylcholine treatments for the patients with nonalcoholic fatty liver disease]. | 2011 | Details |
| A45906 | 22150544 | Aliment Pharmacol Ther | The diagnosis of non-alcoholic fatty liver disease. | 2012 | Details |
| A45907 | 22149573 | Expert Rev Gastroenterol Hepatol | Medical therapy for nonalcoholic fatty liver disease in children and adolescents. | 2012 | Details |
| A45908 | 22144172 | Genes Nutr | Nutrigenomics of hepatic steatosis in a feline model: effect of monosodium glutamate, fructose, and Trans-fat feeding. | 2011 | Details |
| A45909 | 22130312 | Clin Chim Acta | Thyroid function in childhood obesity and metabolic comorbidity. | 2011 | Details |
| A45910 | 25755391 | J Clin Exp Hepatol | Hepatology elsewhere. | 2012 | Details |
| A45911 | 22125461 | ScientificWorldJournal | Advantages and disadvantages of hyperbaric oxygen treatment in mice with obesity hyperlipidemia and steatohepatitis. | 2011 | Details |
| A45912 | 22122483 | Curr Pharm Biotechnol | Intestinal MicrobiOMICS to define health and disease in human and mice. | 2012 | Details |
| A45913 | 22103615 | Biomark Med | Reliability of caspase activity as a biomarker of hepatic apoptosis in nonalcoholic fatty liver disease. | 2011 | Details |
| A45914 | 22102440 | BMJ | Prognosis and staging of non-alcoholic fatty liver disease. | 2011 | Details |
| A45915 | 22101559 | Curr Opin Lipidol | Current world literature. | 2011 | Details |
| A45916 | 22095841 | Hepatology | Endoplasmic reticulum-tethered transcription factor cAMP responsive element-binding protein, hepatocyte specific, regulates hepatic lipogenesis, fatty acid oxidation, and lipolysis upon metabolic stress in mice. | 2012 | Details |
| A45917 | 22093451 | Liver Int | Understanding the relationship between PNPLA3, NAFLD and insulin resistance: do ethnic differences bring more questions or more answers? | 2011 | Details |
| A45918 | 22093450 | Liver Int | Glucagon like-peptide 1 receptor and the liver. | 2011 | Details |
| A45919 | 22089363 | South Med J | Physical activity benefits and risks on the gastrointestinal system. | 2011 | Details |